ArticleAbdominal radiology (New York)2024

Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response.

Seung Ha Cha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.